회사 소개
- 법인명: Chengdu Climb Pharmaceutical Technology Co., Ltd.
- 국제 명칭: 成都克莱蒙医药科技有限公司 (Chengdu Climb Pharmaceutical Technology Co., Ltd.), Chengdu, Sichuan, China
- 브랜드명 / 상호: Climb
- 등록 국가: China
- 주소: Room 909-911, Building C1, No. 88 Keyuan South Road, Tianfu Life Science & Technology Park, Gaoxin District, Chengdu 610041, Sichuan, China • Sichuan
- 설립 연도: 2013
설명:
Chengdu Climb Pharmaceutical Technology Co., Ltd., established in 2013, manufactures and trades active pharmaceutical ingredients and pharmaceutical intermediates and fine chemicals for markets worldwide. The company offers contract manufacturing services and is recognized for its international approvals, experienced R&D staff, production capacity and quality service.
사업 활동
원료의약품(API)
공급업체원료의약품 제조업체제조업체
완제 의약품
제조업체
계약 및 아웃소싱 서비스
서비스 제공업체
판매 시장
- East Asia: China, Democratic People's Republic of Korea, Republic of Korea, Japan
- Western Asia: Cyprus
- Northern Europe: Denmark, Finland, Iceland, Ireland, Norway, Sweden, United Kingdom
- Southern Europe: Andorra, Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain, Vatican City
- Western Europe: Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, Monaco, Netherlands, Switzerland
주요 제품/서비스
- 원료의약품(API): Palbociclib, Etoricoxib, Active Pharmaceutical Ingredients, Brivaracetam, Avibactam Sodium, Apixaban, Vinpocetine, Parecoxib Sodium, Rupatadine fumarate, Macitentan, Moxifloxacin hydrochloride, Anacetrapib, Anamorelin, AZD9291, Cinacalcet HCl, Desvenlafaxine succinate, Macimorelin Acetate, Parecoxib Sodium cas:197502-82-2, Phenylethyl caffeate, ROLAPITANT, Tirofiban hydrochloride monohydrate
- 완제 의약품: Lactulose oral solution, Finished antibiotic medicines
- 제약용 화학물질: Active Pharmaceutical Ingredients, Pharmaceutical Intermediates, (R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol, 6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one, (S,S)-2,8-Diazabicyclo[4,3,0]nonane, Vincamine, 1-(6-Methylpyridin-3-yl)-2-[4(methylsulfonyl)phenyl]ethanone, 4-Methylsulfonyl phenyl acetic acid, 1-(6-methylpyridin-3-yl)-2-(4-(methylthio)phenyl)ethanone, 10,10-dimethylanthrone, 2-Chloro-1,3-bis(dimenthylamino)trimethinium hexafluorophosphate, 2-chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3d] pyrimidine-6-carboxamide, 2'-(Chloromethyl)-4-fluoro-5-isopropyl-2-Methoxy-4'- (trifluoroMethyl)-1,1'-biphenyl, 2-(trifluoromethyl)pyridin -4-amine, 2,4-dichloro-6-(6-(trifluoromethyl)pyridin -2-yl)-1,3,5-triazine, (2S,5R)- 5-(benzyloxyamino)piperidine -2-carboxamide, (2S,5R)-5-[(benzyloxy)amino]piperidine -2-carboxylic acid benzyl ester ethanedioate, (2s,5r)-5-((phenylmethoxy)amino) -2-piperidinecarboxylic acid ethyl ester ethanedioate, (2S,5R)-benzyl 5-(benzyloxyamino)piperidine -2-carboxylate, 3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone, 3-(Chloromethyl)-5-methylpyridine, (3R)-3-(Phenylmethyl)-3-piperidinecarboxylic acid trimethylhydrazide, 4-(4-Chlorobutyl)pyridine hydrochloride, 4-[6-[(6-Bromo-8-cyclopentyl-7,8-dihydro-5-methyl-7- oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridin, 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate, 4'-FLUORO-2'-METHOXY-5'-ISOPROPYL-4-TRIFLUOROMETHYL-1,1'-BIPHENYL-2-METHANOL, 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo- 1H-pyrazolo[3,4-c]pyridine-3-carboxy, (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl] -4-methyl-1,3-oxazolidin- 2-one, 5-(4-Bromophenyl)-4,6-dichloropyrimidine, 5-Bromo-2-chloropyrimidine, 5-hydroxy-4-propyl-2(5H)-furanone, 5-Methyl-3,4-diphenyl- Isoxazole, 6-Benzofurancarboxylic acid, 6-Isoquinolinecarboxylic acid, 5,7-dichloro-1,2,3,4-tetrahydro-, hydrochloride, Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate, Methyl-6-methylnicotinate, methyl 6-(trifluoromethyl)picolinate, N-[2-Chloro-3-bis(dimethylamino)trimethinium, N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine, N-Butylsulfonyl-L-tyrosine, N-Propyl-sulfamide potassium salt, N-Propyl-sulfamide sodium salt, N-Propylsulfamide, N1-[2-(diMethylaMino)ethyl] -5-Methoxy-N1-Methyl-N4-[4-(1- Methyl-1H-indol-3-yl)-2-pyriMidinyl]benze, (R)-1-(1-(bromomethoxy)ethyl) -3,5-bis(trifluoromethy l)benzene, (R)-Dihydro-4-propyl-2(3H)-furanone, Rucaparib, Tabersonine, VALDECOXIB
- ATC 분류체계 (해부치료화학분류): Desloratadine
당사 제품 & 서비스
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Sell · Pharma Chemicals
![(2S,5R)-5-[(benzyloxy)amino]piperidine -2-carboxylic acid benzyl ester ethanedioate](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F2s5r-5-benzyloxyaminopiperidine--2-carbo-78005.jpg&w=640&q=75)
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Active Pharmaceutical Ingredients (APIs)
![Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fethyl-chloro4-methoxyphenylhydrazonoacet-78013.jpg&w=640&q=75)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
![N1-[2-(diMethylaMino)ethyl] -5-Methoxy-N1-Methyl-N4-[4-(1- Methyl-1H-indol-3-yl)-2-pyriMidinyl]benze](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fn1-2-dimethylaminoethyl--5-methoxy-n1-me-78016.jpg&w=640&q=75)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
인증
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기